服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Renvistobart Biosimilar] (MABL-5157) | MABL-5157 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1;PDL1/CD274 mAbs [Reozalimab Biosimilar] (MABL-5158) | MABL-5158 | ELISA, FACS, Functional assay, in vivo binding | G1;G1, Kappa;Lambda |
| Anti-IL5 mAbs [Reslizumab Biosimilar] (MABL-5159) | MABL-5159 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-SOST mAbs [Resugosbart Biosimilar] (MABL-5160) | MABL-5160 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-RSV gpF mAbs [Retavibart Biosimilar] (MABL-5161) | MABL-5161 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Retifanlimab Biosimilar] (MABL-5162) | MABL-5162 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Retlirafusp Biosimilar] (MABL-5163) | MABL-5163 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TNFRSF4/CD134/OX40 mAbs [Revdofilimab Biosimilar] (MABL-5164) | MABL-5164 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3;SIGLEC2/CD22 mAbs [Rezetamig Biosimilar] (MABL-5165) | MABL-5165 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-KLRB1 mAbs [Rezorstobart Biosimilar] (MABL-5166) | MABL-5166 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C1S mAbs [Riliprubart Biosimilar] (MABL-5167) | MABL-5167 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-GDF15/MIC1/MIC-1/NAG1/NAG-1/PTGFB mAbs [Rilogrotug Biosimilar] (MABL-5168) | MABL-5168 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HGF/SF mAbs [Rilotumumab Biosimilar] (MABL-5169) | MABL-5169 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-IL31 (Canine) mAbs [Riltovetbart Biosimilar] (MABL-5170) | MABL-5170 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-KDR/CD309/VEGFR2 mAbs [Ramucirumab Biosimilar] (MABL-5141) | MABL-5141 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB mAbs [Ranevetmab Biosimilar] (MABL-5142) | MABL-5142 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-VEGFA mAbs [Ranibizumab Biosimilar] (MABL-5143) | MABL-5143 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-KARS1 mAbs [Rapaprutug Biosimilar] (MABL-5144) | MABL-5144 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-TNFRSF5/CD40 mAbs [Ravagalimab Biosimilar] (MABL-5145) | MABL-5145 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5 mAbs [Ravulizumab Biosimilar] (MABL-5146) | MABL-5146 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn